Jim Cramer highlights three stocks with different outlooks: CVS Health is considered 'insanely cheap' at around $86 due to overblown concerns about its Caremark unit and strong overall performance. ON Semiconductor is gaining after resolving Synaptics deal issues, with its AI data center business growing rapidly. Grail, a cancer detection test maker, is viewed as too expensive at 34 times sales and remains speculative due to pending FDA approval expected in early 2027. Investors should note CVS's undervaluation, ON Semi's growth potential, and Grail's high risk and price.
CVS Health trades at USD 87.96 on Pluang as of Oct 07, 2026 20:51 WIB, showing a 1.77% gain in the past day despite 100% sell order activity on the platform. ON Semiconductor is priced at USD 84.23 with a 2.40% decline over the same period, yet it sees strong buying interest with 85% buy orders and a typical hold time of just 4 days. These figures highlight contrasting investor behaviors for the stocks discussed in the news.
CVS Health has opened its first pharmacy-focused CVS Pharmacy in Roxbury, Boston, with plans to open nearly 20 such locations nationwide in 2026. These smaller, community-tailored pharmacies aim to improve access to prescription medications, immuniza...
In response to a measles outbreak and statewide emergency in New York, CVS Health is offering measles-mumps-rubella (MMR) vaccinations at over 530 CVS Pharmacy locations and MinuteClinic sites across the state. The MMR vaccine is crucial to prevent t...
CVS Health announced it will hold a conference call on November 4, 2026, to discuss its third quarter financial results. The event will be webcast live on the company's investor relations website and archived for one year. CVS Health operates around ...
Aetna, part of CVS Health, announced its 2027 Medicare offerings featuring $0 copays on Tier 1 drugs, vaccines, and key preventive services like annual physicals and screenings. The plans expand Chronic Condition Special Needs Plans to 25 states and ...
